ArticleOncotarget2016

Brother of the regulator of the imprinted site (BORIS) variant subfamily 6 is involved in cervical cancer stemness and can be a target of immunotherapy.

Takuya Asano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.